258 related articles for article (PubMed ID: 18332450)
1. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia.
Li H; Wang SX
Perit Dial Int; 2008; 28(2):149-54. PubMed ID: 18332450
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].
Li H; Wang SX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):457-62. PubMed ID: 19567093
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
Dittrich E; Schillinger M; Sunder-Plassmann G; Hörl WH; Vychytil A
Perit Dial Int; 2002; 22(1):60-6. PubMed ID: 11929146
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M
Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499
[TBL] [Abstract][Full Text] [Related]
6. Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study.
Ahsan N
J Am Soc Nephrol; 1998 Apr; 9(4):664-8. PubMed ID: 9555669
[TBL] [Abstract][Full Text] [Related]
7. Iron supplementation in haemodialysis--practical clinical guidelines.
Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Goldstein SL; Morris D; Warady BA
Am J Kidney Dis; 2013 Apr; 61(4):588-97. PubMed ID: 23245582
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Macdougall IC; Strauss WE; McLaughlin J; Li Z; Dellanna F; Hertel J
Clin J Am Soc Nephrol; 2014 Apr; 9(4):705-12. PubMed ID: 24458078
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
Barraclough KA; Brown F; Hawley CM; Leary D; Noble E; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Johnson DW
Nephrol Dial Transplant; 2012 Nov; 27(11):4146-53. PubMed ID: 22962411
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
Wall GC; Pauly RA
Am J Health Syst Pharm; 2008 Jan; 65(2):150-3. PubMed ID: 18192261
[TBL] [Abstract][Full Text] [Related]
12. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Bhavi SB; Jaju PB
BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
[TBL] [Abstract][Full Text] [Related]
14. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
15. [Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Yin L; Chen X; Chen J; Cheng M; Peng Y; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):844-8. PubMed ID: 22954919
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
Deng Y; Wu J; Jia Q
Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients.
Mitsopoulos E; Lysitska A; Pateinakis P; Lamprou V; Intzevidou E; Minasidis I; Katsaounou C; Kougioumtzidou O; Anagnostou N; Lemonidis N; Papadopoulou D
Int Urol Nephrol; 2020 Feb; 52(2):387-392. PubMed ID: 31894555
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Charytan C; Levin N; Al-Saloum M; Hafeez T; Gagnon S; Van Wyck DB
Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron.
Trivedi HS; Brooks BJ
Am J Nephrol; 2003; 23(2):78-85. PubMed ID: 12481145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
